MCC
GSK icon

Mid Continent Capital’s GSK GSK Stock Holding History

Mid Continent Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,496
Closed -$286K – 280
2015
Q2 		$286K Buy
5,496
+500
+10% +$28.2K 0.02% 268
2015
Q1 		$288K Buy
4,996
+1,000
+25% +$57.3K 0.02% 267
2014
Q4 		$214K Buy
+3,996
New +$224K 0.01% 291

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mid Continent Capital's GSK Position: Q3 2015 in Review

Mid Continent Capital sold out of GSK (GSK) in Q3 2015, closing a stake of 5,496 shares — an estimated $286K sold.

Mid Continent Capital first reported a position in GSK in Q4 2014 and held it in 3 quarters. The position peaked at $288K in Q1 2015. 707 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • Mid Continent Capital reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • Mid Continent Capital sold 5,496 GSK shares in Q3 2015, an estimated $286K.
  • Mid Continent Capital first reported a position in GSK in Q4 2014 and held it in 3 quarters.
  • Mid Continent Capital's GSK position peaked at $288K in Q1 2015.
  • 707 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.